Clinical Trials Logo

Psoriatic Nail clinical trials

View clinical trials related to Psoriatic Nail.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05621369 Recruiting - Psoriasis Clinical Trials

Psorcast Mobile Study

Start date: January 1, 2022
Phase:
Study type: Observational

The purpose of this study is to understand variation in the symptoms of psoriasis and psoriatic arthritis using simple, scalable smartphone-based measurements. This study uses an iPhone app to record these symptoms through questionnaires and sensors.

NCT ID: NCT05144165 Recruiting - Psoriasis Clinical Trials

Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines

Start date: November 8, 2021
Phase:
Study type: Observational

French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults have been developed by the psoriasis research group of the French Society of Dermatology using literature available until July 2017 (Amatore et al, 2019). Because several systemic treatments have been marketed since then, new guidelines are mandatory. The aim of this study coordinated by the Centre of Evidence of the French Society of Dermatology is to update the available French guidelines using a Delphi method.

NCT ID: NCT05135312 Recruiting - Psoriasis Clinical Trials

Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging

Start date: August 9, 2021
Phase: Phase 4
Study type: Interventional

OptiSkin is now enrolling a new study to monitor nail changes in patients with nail psoriasis treated with Enbrel® (etanercept) with optical coherence tomography (OCT).

NCT ID: NCT04950218 Recruiting - Stroke Clinical Trials

The Psoriasis Echo Study

Start date: September 1, 2021
Phase:
Study type: Observational

In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.